Beacon Roofing Supply Inc (NASDAQ: BECN) has reported E.P.S. of $2.03 for its second fiscal quarter (ending June 30) versus $2.02 for the same period a year ago. E.P.S. were $-0.56 for the latest four […]
Alnylam Pharmaceuticals Inc (NASDAQ: ALNY) stock closed at $268.61 on 8/1/24 after a major increase of 13.1%. Moreover, this advance was accompanied by unusually high trading volume at 196% of normal. The stock has been […]
Stock Rating Upgrade In recent days the Value Trend Rating for Adverum Biotechnologies Inc (NASDAQ: ADVM) improved from D to C reflecting improving fundamentals and high Appreciation Potential. Recent Price Action On 8/1/24, Adverum Biotechnologies […]
For its second fiscal quarter (ending June 30), iRadimed Corp (NASDAQ: IRMD) has reported E.P.S. of $0.39 compared to $0.33 a year ago. E.P.S. were $1.47 for the latest four quarters through June 30 versus […]
Stock Rating Upgrade Reflecting improving fundamentals and high Appreciation Potential, the Value Trend Rating for VSE Corp (NASDAQ: VSEC) improved of late. VSEC’s current Value Trend Rating is B and the prior Rating was C. […]
Ultra Clean Holdings Inc (NASDAQ: UCTT) suffers from exceptional negative changes in investment behavior: the stock’s recent price decline challenged its longer term uptrend, its shorter term price trend turned down, and the stock fell […]
Stock Rating Downgrade Reflecting eroding fundamentals and low Appreciation Potential, the Value Trend Rating for Turtle Beach Corp (NASDAQ: HEAR) weakened of late. HEAR’s current Value Trend Rating is C and the prior Rating was […]
Sleep Number Corp (NASDAQ: SNBR) stock enjoyed a major increase of 19.9% on 8/1/24. The shares closed at $14.15. Moreover, trading volume in this advance was exceptionally high at 270% of normal. The stock has […]
Stock Rating Upgrade In the last week the Value Trend Rating for Silicom Ltd (NASDAQ: SILC) improved from D to C reflecting improving fundamentals and high Appreciation Potential. Recent Price Action Silicom Ltd (NASDAQ: SILC) […]
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) has reported earnings for its second fiscal quarter (ending June 30) of $13.25 versus $9.05 for the same period a year ago. E.P.S. were $40.31 for the latest four quarters […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research